Bonomarlot
What is it?
Animal bone-marrow peptide mixture described in an institute anemia report. It is distinct from synthetic Stemokin and from historical Haemalin.
Research context
Animal bone-marrow peptide mixture described in an institute anemia report. It is distinct from synthetic Stemokin and from historical Haemalin.
- Working classification
- Archival preparation lead
- Research collection
- Peptide bioregulation · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —Small adjunctive anemia comparison
- Study methods
- —Original preparation and study methods await verification
- Independent replication
- —Related reports are not automatically independent evidence
- Source access
- —English institute-report reproduction; Russian original requires comparison
- Safety evidence
- —Clinical safety, product equivalence and interactions not established by this collection
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Explore the expanded peptide research collection and unresolved source trails ↗
Linked sources
Explore the research map and unresolved leads ↗
Bonomarlot: institute clinical report
Animal bone-marrow peptide mixture · Originating-institute report; commercial reproduction
A. A. Veretenko, O. U. Raigorodsky · Institute clinical-report compilation; commercial English reproduction
Institute report of 26 women with nutritional iron-deficiency anemia, divided 15/11. Both groups received conventional care. Reported hemoglobin was higher with adjunctive Bonomarlot; this does not establish stem-cell regeneration or benefit in other conditions.
- Population / setting
- 26 women with nutritional iron-deficiency anemia
- What was checked
- English reproduction, pages 4-7, checked. Russian original and complete methods remain review targets.
Limitations & review scope
- Small adjunctive comparison; allocation and blinding unclear.
- Reported percentages and table footnotes require reconciliation with the Russian original.
- Commercial reproduction is not independent replication or peer review.
Source checked 2026-10-02. This is a source-linked record, not a completed evidence review.